MPM BioVentures 2014 GP LLC
Insider CIK 1765091 · ONCR 10% owner · TRDA 10% owner · HARP 10% owner · TCRR 10% owner · HOWL 10% owner · RPTX 10% owner · ITOS 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| TRDA Entrada Therapeutics, Inc. | S Sale | 2026-09-09 | 2026-09-09 | 28,837 | $7.13 | $205.6K | 3,885,115 | SEC↗ |
| TRDA Entrada Therapeutics, Inc. | S Sale | 2026-09-09 | 2026-09-09 | 28,837 | $7.13 | $205.6K | 3,885,115 | SEC↗ |
| TRDA Entrada Therapeutics, Inc. | S Sale | 2026-09-08 | 2026-09-09 | 192,500 | $7.41 | $1.43M | 3,913,952 | SEC↗ |
| TRDA Entrada Therapeutics, Inc. | S Sale | 2026-09-08 | 2026-09-09 | 192,500 | $7.41 | $1.43M | 3,913,952 | SEC↗ |
| TRDA Entrada Therapeutics, Inc. | S Sale | 2026-09-04 | 2026-09-09 | 38,500 | $7.11 | $273.7K | 4,106,452 | SEC↗ |
| TRDA Entrada Therapeutics, Inc. | S Sale | 2026-09-04 | 2026-09-09 | 38,500 | $7.11 | $273.7K | 4,106,452 | SEC↗ |
| TRDA Entrada Therapeutics, Inc. | S Sale | 2026-09-03 | 2026-09-03 | 32,263 | $7.17 | $231.3K | 4,144,952 | SEC↗ |
| TRDA Entrada Therapeutics, Inc. | S Sale | 2026-09-03 | 2026-09-03 | 32,263 | $7.17 | $231.3K | 4,144,952 | SEC↗ |
| TRDA Entrada Therapeutics, Inc. | S Sale | 2026-09-02 | 2026-09-03 | 25,131 | $7.19 | $180.7K | 4,177,215 | SEC↗ |
| TRDA Entrada Therapeutics, Inc. | S Sale | 2026-09-02 | 2026-09-03 | 25,131 | $7.19 | $180.7K | 4,177,215 | SEC↗ |
| TRDA Entrada Therapeutics, Inc. | S Sale | 2026-09-01 | 2026-09-03 | 29,088 | $7.06 | $205.4K | 4,202,346 | SEC↗ |
| TRDA Entrada Therapeutics, Inc. | S Sale | 2026-09-01 | 2026-09-03 | 29,088 | $7.06 | $205.4K | 4,202,346 | SEC↗ |
| TRDA Entrada Therapeutics, Inc. | S Sale | 2026-08-31 | 2026-08-31 | 44,259 | $6.99 | $309.4K | 4,231,434 | SEC↗ |
| TRDA Entrada Therapeutics, Inc. | S Sale | 2026-08-31 | 2026-08-31 | 44,259 | $6.99 | $309.4K | 4,231,434 | SEC↗ |
| TRDA Entrada Therapeutics, Inc. | S Sale | 2026-08-28 | 2026-08-31 | 3,733 | $7.01 | $26.2K | 4,275,693 | SEC↗ |
| TRDA Entrada Therapeutics, Inc. | S Sale | 2026-08-28 | 2026-08-31 | 3,733 | $7.01 | $26.2K | 4,275,693 | SEC↗ |
| TRDA Entrada Therapeutics, Inc. | S Sale | 2026-08-27 | 2026-08-31 | 38,922 | $7.20 | $280.2K | 4,279,426 | SEC↗ |
| TRDA Entrada Therapeutics, Inc. | S Sale | 2026-08-27 | 2026-08-31 | 38,922 | $7.20 | $280.2K | 4,279,426 | SEC↗ |
| TRDA Entrada Therapeutics, Inc. | S Sale | 2026-08-26 | 2026-08-26 | 14,569 | $7.06 | $102.9K | 4,318,348 | SEC↗ |
| TRDA Entrada Therapeutics, Inc. | S Sale | 2026-08-26 | 2026-08-26 | 14,569 | $7.06 | $102.9K | 4,318,348 | SEC↗ |
| TRDA Entrada Therapeutics, Inc. | S Sale | 2026-08-25 | 2026-08-26 | 26,522 | $7.54 | $200.0K | 4,332,917 | SEC↗ |
| TRDA Entrada Therapeutics, Inc. | S Sale | 2026-08-25 | 2026-08-26 | 26,522 | $7.54 | $200.0K | 4,332,917 | SEC↗ |
| TRDA Entrada Therapeutics, Inc. | S Sale | 2026-08-24 | 2026-08-26 | 21,623 | $7.34 | $158.7K | 4,359,439 | SEC↗ |
| TRDA Entrada Therapeutics, Inc. | S Sale | 2026-08-24 | 2026-08-26 | 21,623 | $7.34 | $158.7K | 4,359,439 | SEC↗ |
| HOWL Werewolf Therapeutics, Inc | S Sale | 2025-12-04 | 2025-12-04 | 83,230 | $0.97 | $80.7K | 4,784,111 | SEC↗ |
| HOWL Werewolf Therapeutics, Inc | S Sale | 2025-12-03 | 2025-12-04 | 57,225 | $0.87 | $49.8K | 4,867,341 | SEC↗ |
| HOWL Werewolf Therapeutics, Inc | S Sale | 2025-12-02 | 2025-12-04 | 59,277 | $0.89 | $52.8K | 4,924,566 | SEC↗ |
| HOWL Werewolf Therapeutics, Inc | S Sale | 2025-12-01 | 2025-12-01 | 60,917 | $0.94 | $57.3K | 4,983,843 | SEC↗ |
| HOWL Werewolf Therapeutics, Inc | S Sale | 2025-11-28 | 2025-12-01 | 20,277 | $0.99 | $20.1K | 5,044,760 | SEC↗ |
| HOWL Werewolf Therapeutics, Inc | S Sale | 2025-11-26 | 2025-12-01 | 60,733 | $0.98 | $59.5K | 5,065,037 | SEC↗ |
| HOWL Werewolf Therapeutics, Inc | S Sale | 2025-11-25 | 2025-11-25 | 42,533 | $0.92 | $39.1K | 5,125,770 | SEC↗ |
| HOWL Werewolf Therapeutics, Inc | S Sale | 2025-11-24 | 2025-11-25 | 88,802 | $0.98 | $87.0K | 5,168,303 | SEC↗ |
| HOWL Werewolf Therapeutics, Inc | S Sale | 2025-11-21 | 2025-11-25 | 64,331 | $0.83 | $53.4K | 5,257,105 | SEC↗ |
| HOWL Werewolf Therapeutics, Inc | S Sale | 2025-11-20 | 2025-11-20 | 41,152 | $0.89 | $36.6K | 5,321,436 | SEC↗ |
| HOWL Werewolf Therapeutics, Inc | S Sale | 2025-11-19 | 2025-11-20 | 66,324 | $0.94 | $62.3K | 5,362,588 | SEC↗ |
| HOWL Werewolf Therapeutics, Inc | S Sale | 2025-11-18 | 2025-11-20 | 52,627 | $0.93 | $48.9K | 5,428,912 | SEC↗ |
| HOWL Werewolf Therapeutics, Inc | S Sale | 2025-11-17 | 2025-11-17 | 57,061 | $0.95 | $54.2K | 5,481,539 | SEC↗ |
| HOWL Werewolf Therapeutics, Inc | S Sale | 2025-11-14 | 2025-11-17 | 61,640 | $0.93 | $57.3K | 5,538,600 | SEC↗ |
| HOWL Werewolf Therapeutics, Inc | S Sale | 2025-11-13 | 2025-11-17 | 90,951 | $0.98 | $89.1K | 5,600,240 | SEC↗ |
| HOWL Werewolf Therapeutics, Inc | S Sale | 2025-11-12 | 2025-11-12 | 40,669 | $1.09 | $44.3K | 5,691,191 | SEC↗ |
| HOWL Werewolf Therapeutics, Inc | S Sale | 2025-11-11 | 2025-11-12 | 55,810 | $1.14 | $63.6K | 5,731,860 | SEC↗ |
| HOWL Werewolf Therapeutics, Inc | S Sale | 2025-11-10 | 2025-11-12 | 48,570 | $1.18 | $57.3K | 5,787,670 | SEC↗ |
| HOWL Werewolf Therapeutics, Inc | S Sale | 2025-11-07 | 2025-11-12 | 68,480 | $1.11 | $76.0K | 5,836,240 | SEC↗ |
| HOWL Werewolf Therapeutics, Inc | S Sale | 2025-11-06 | 2025-11-06 | 54,452 | $1.21 | $65.9K | 5,904,720 | SEC↗ |
| HOWL Werewolf Therapeutics, Inc | S Sale | 2025-11-05 | 2025-11-06 | 47,950 | $1.22 | $58.5K | 5,959,172 | SEC↗ |
| HOWL Werewolf Therapeutics, Inc | S Sale | 2025-11-04 | 2025-11-06 | 140,488 | $1.22 | $171.4K | 6,007,122 | SEC↗ |
| HOWL Werewolf Therapeutics, Inc | S Sale | 2025-11-03 | 2025-11-03 | 94,063 | $1.29 | $121.3K | 6,147,610 | SEC↗ |
| HOWL Werewolf Therapeutics, Inc | S Sale | 2025-10-31 | 2025-11-03 | 114,044 | $1.28 | $146.0K | 6,241,673 | SEC↗ |
| HOWL Werewolf Therapeutics, Inc | S Sale | 2025-10-30 | 2025-11-03 | 86,936 | $1.43 | $124.3K | 6,355,717 | SEC↗ |
| HOWL Werewolf Therapeutics, Inc | S Sale | 2025-10-29 | 2025-10-29 | 134,240 | $1.55 | $208.1K | 6,442,653 | SEC↗ |
| HOWL Werewolf Therapeutics, Inc | S Sale | 2025-10-28 | 2025-10-29 | 69,068 | $1.64 | $113.3K | 6,576,893 | SEC↗ |
| HOWL Werewolf Therapeutics, Inc | S Sale | 2025-10-27 | 2025-10-29 | 72,709 | $1.72 | $125.1K | 6,645,961 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2025-05-13 | 2025-05-15 | 630,191 | $8.06 | $5.08M | 2,108,594 | SEC↗ |
| HOWL Werewolf Therapeutics, Inc | X Exercise deriv | 2025-03-27 | 2025-04-30 | 18,743 | — | $0 | 0 | SEC↗ |
| HOWL Werewolf Therapeutics, Inc | X Exercise deriv | 2025-03-27 | 2025-04-30 | 4,015 | — | $0 | 0 | SEC↗ |
| HOWL Werewolf Therapeutics, Inc | S Sale | 2025-03-27 | 2025-04-30 | 1,963 | $1.05 | $2.1K | 3,208,793 | SEC↗ |
| HOWL Werewolf Therapeutics, Inc | X Exercise | 2025-03-27 | 2025-04-30 | 22,758 | $0.09 | $2.0K | 3,210,756 | SEC↗ |
| TRDA Entrada Therapeutics, Inc. | S Sale | 2024-12-11 | 2024-12-12 | 21,787 | $20.23 | $440.8K | 4,381,062 | SEC↗ |
| TRDA Entrada Therapeutics, Inc. | S Sale | 2024-12-10 | 2024-12-12 | 22,935 | $20.77 | $476.4K | 4,402,849 | SEC↗ |
| TCRR TCR2 THERAPEUTICS INC. | J Other | 2023-06-01 | 2023-06-05 | 4,158,964 | — | $0 | 0 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2022-01-05 | 2022-01-06 | 18,135 | $42.03 | $762.2K | 2,738,785 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2022-01-04 | 2022-01-06 | 7,671 | $46.47 | $356.5K | 2,756,920 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2022-01-04 | 2022-01-06 | 6,768 | $45.32 | $306.7K | 2,764,591 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2022-01-04 | 2022-01-06 | 94,745 | $42.05 | $3.98M | 2,790,725 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2022-01-04 | 2022-01-06 | 19,366 | $43.20 | $836.6K | 2,771,359 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2021-12-07 | 2021-12-07 | 17,962 | $33.15 | $595.4K | 2,886,964 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2021-12-07 | 2021-12-07 | 1,494 | $34.11 | $51.0K | 2,885,470 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2021-12-06 | 2021-12-07 | 60 | $35.04 | $2.1K | 2,904,926 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2021-12-06 | 2021-12-07 | 508 | $34.08 | $17.3K | 2,904,986 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2021-12-06 | 2021-12-07 | 8,469 | $32.35 | $274.0K | 2,906,665 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2021-12-06 | 2021-12-07 | 1,171 | $33.57 | $39.3K | 2,905,494 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2021-12-03 | 2021-12-07 | 2,419 | $35.44 | $85.7K | 2,915,313 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2021-12-03 | 2021-12-07 | 179 | $36.26 | $6.5K | 2,915,134 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2021-12-03 | 2021-12-07 | 17,569 | $34.68 | $609.3K | 2,917,732 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2021-12-02 | 2021-12-02 | 29,757 | $33.74 | $1.00M | 2,942,731 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2021-12-02 | 2021-12-02 | 7,430 | $34.83 | $258.8K | 2,935,301 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2021-12-01 | 2021-12-02 | 896 | $35.34 | $31.7K | 2,972,488 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2021-12-01 | 2021-12-02 | 5,457 | $34.61 | $188.9K | 2,973,384 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2021-12-01 | 2021-12-02 | 6,042 | $33.82 | $204.3K | 2,978,841 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2021-11-30 | 2021-12-02 | 5,861 | $34.62 | $202.9K | 3,012,959 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2021-11-30 | 2021-12-02 | 28,076 | $35.19 | $988.0K | 2,984,883 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2021-11-29 | 2021-11-30 | 10,073 | $34.46 | $347.1K | 3,019,118 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2021-11-29 | 2021-11-30 | 298 | $35.37 | $10.5K | 3,018,820 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2021-11-26 | 2021-11-30 | 6,129 | $36.03 | $220.8K | 3,029,191 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2021-11-26 | 2021-11-30 | 6,545 | $35.49 | $232.3K | 3,035,320 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2021-11-24 | 2021-11-24 | 13,126 | $37.02 | $485.9K | 3,041,865 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2021-11-24 | 2021-11-24 | 4,868 | $35.20 | $171.4K | 3,073,334 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2021-11-24 | 2021-11-24 | 18,343 | $36.05 | $661.3K | 3,054,991 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2021-11-23 | 2021-11-24 | 359 | $36.50 | $13.1K | 3,078,202 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2021-11-23 | 2021-11-24 | 19,645 | $36.21 | $711.3K | 3,078,561 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2021-11-22 | 2021-11-24 | 11,807 | $37.81 | $446.4K | 3,098,206 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2021-11-22 | 2021-11-24 | 9,307 | $37.16 | $345.8K | 3,110,013 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | J Other | 2021-11-17 | 2021-11-24 | 15,671 | — | $0 | 3,119,320 | SEC↗ |
| TRDA Entrada Therapeutics, Inc. | C Conversion deriv | 2021-11-02 | 2021-11-04 | 3,683,241 | — | $0 | 0 | SEC↗ |
| TRDA Entrada Therapeutics, Inc. | C Conversion deriv | 2021-11-02 | 2021-11-04 | 27,617,675 | — | $0 | 0 | SEC↗ |
| TRDA Entrada Therapeutics, Inc. | C Conversion | 2021-11-02 | 2021-11-04 | 509,024 | — | $0 | 4,325,784 | SEC↗ |
| TRDA Entrada Therapeutics, Inc. | P Buy | 2021-11-02 | 2021-11-04 | 100,000 | $20.00 | $2.00M | 4,425,784 | SEC↗ |
| TRDA Entrada Therapeutics, Inc. | C Conversion | 2021-11-02 | 2021-11-04 | 3,816,760 | — | $0 | 3,816,760 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2021-10-18 | 2021-10-18 | 6,167 | $27.14 | $167.4K | 3,134,991 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2021-10-15 | 2021-10-18 | 2,039 | $28.01 | $57.1K | 3,141,158 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2021-10-15 | 2021-10-18 | 8,893 | $27.53 | $244.8K | 3,143,197 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2021-10-14 | 2021-10-14 | 27,320 | $27.30 | $745.8K | 3,152,090 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2021-10-13 | 2021-10-14 | 20,929 | $27.13 | $567.8K | 3,179,410 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2021-10-12 | 2021-10-14 | 8,521 | $27.09 | $230.8K | 3,200,339 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2021-10-11 | 2021-10-12 | 48,812 | $27.24 | $1.33M | 3,208,860 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2021-10-08 | 2021-10-12 | 2,032 | $27.01 | $54.9K | 3,257,672 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2021-10-07 | 2021-10-12 | 1,149 | $27.00 | $31.0K | 3,259,704 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2021-10-04 | 2021-10-05 | 20,711 | $27.06 | $560.4K | 3,260,853 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2021-10-01 | 2021-10-05 | 6,855 | $27.00 | $185.1K | 3,281,564 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2021-09-30 | 2021-09-30 | 2,292 | $27.00 | $61.9K | 3,288,419 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2021-09-28 | 2021-09-30 | 19,214 | $27.00 | $518.8K | 3,290,711 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2021-09-27 | 2021-09-27 | 11,625 | $27.09 | $314.9K | 3,309,925 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2021-09-24 | 2021-09-27 | 4,913 | $27.81 | $136.6K | 3,321,550 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2021-09-23 | 2021-09-27 | 36,213 | $27.96 | $1.01M | 3,327,180 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2021-09-23 | 2021-09-27 | 717 | $28.38 | $20.3K | 3,326,463 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2021-09-22 | 2021-09-23 | 14,294 | $27.54 | $393.7K | 3,363,393 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2021-09-21 | 2021-09-23 | 19,635 | $27.47 | $539.4K | 3,377,687 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2021-09-20 | 2021-09-20 | 13,701 | $27.84 | $381.4K | 3,397,322 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2021-09-20 | 2021-09-20 | 10,602 | $27.03 | $286.6K | 3,411,023 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2021-09-17 | 2021-09-20 | 45,698 | $28.82 | $1.32M | 3,421,625 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2021-09-16 | 2021-09-20 | 21,253 | $28.47 | $605.1K | 3,467,323 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2021-09-15 | 2021-09-16 | 23,113 | $27.79 | $642.3K | 3,489,567 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2021-09-15 | 2021-09-16 | 991 | $28.15 | $27.9K | 3,488,576 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2021-09-14 | 2021-09-16 | 17,938 | $27.50 | $493.3K | 3,516,303 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2021-09-14 | 2021-09-16 | 3,623 | $27.99 | $101.4K | 3,512,680 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2021-09-13 | 2021-09-13 | 21,384 | $27.64 | $591.1K | 3,534,241 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2021-09-10 | 2021-09-13 | 6,771 | $28.73 | $194.5K | 3,555,625 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2021-09-10 | 2021-09-13 | 6,760 | $27.86 | $188.3K | 3,562,396 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2021-09-09 | 2021-09-13 | 22,725 | $28.97 | $658.3K | 3,569,156 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2021-09-08 | 2021-09-08 | 940 | $29.10 | $27.4K | 3,591,881 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2021-09-08 | 2021-09-08 | 11,152 | $28.61 | $319.1K | 3,592,821 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2021-09-07 | 2021-09-08 | 30,474 | $29.18 | $889.2K | 3,635,313 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | J Other | 2021-09-07 | 2021-09-08 | 31,340 | — | $0 | 3,603,793 | SEC↗ |
| HOWL Werewolf Therapeutics, Inc | C Conversion deriv | 2021-05-04 | 2021-05-06 | 6,621,546 | — | $0 | 0 | SEC↗ |
| HOWL Werewolf Therapeutics, Inc | C Conversion deriv | 2021-05-04 | 2021-05-06 | 19,925,321 | — | $0 | 0 | SEC↗ |
| HOWL Werewolf Therapeutics, Inc | C Conversion | 2021-05-04 | 2021-05-06 | 2,298,430 | — | $0 | 2,298,430 | SEC↗ |
| HOWL Werewolf Therapeutics, Inc | P Buy | 2021-05-04 | 2021-05-06 | 125,759 | $16.00 | $2.01M | 3,187,998 | SEC↗ |
| HOWL Werewolf Therapeutics, Inc | C Conversion | 2021-05-04 | 2021-05-06 | 763,809 | — | $0 | 3,062,239 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | S Sale | 2021-04-15 | 2021-04-15 | 1,052 | $20.49 | $21.6K | 3,220,844 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | S Sale | 2021-04-14 | 2021-04-15 | 1,550 | $20.83 | $32.3K | 3,221,896 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | S Sale | 2021-04-14 | 2021-04-15 | 121 | $20.06 | $2.4K | 3,223,446 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | S Sale | 2021-04-13 | 2021-04-15 | 286 | $20.08 | $5.7K | 3,223,567 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | S Sale | 2021-04-13 | 2021-04-15 | 1,657 | $19.35 | $32.1K | 3,223,853 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | S Sale | 2021-04-12 | 2021-04-13 | 48 | $22.68 | $1.1K | 3,225,510 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | S Sale | 2021-04-12 | 2021-04-13 | 1,637 | $20.72 | $33.9K | 3,226,369 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | S Sale | 2021-04-12 | 2021-04-13 | 811 | $21.52 | $17.5K | 3,225,558 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | S Sale | 2021-04-09 | 2021-04-13 | 10,300 | $23.67 | $243.8K | 3,228,006 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2021-04-09 | 2021-04-13 | 119 | $29.99 | $3.6K | 3,665,787 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2021-04-08 | 2021-04-09 | 19,057 | $30.51 | $581.4K | 3,666,153 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2021-04-08 | 2021-04-09 | 247 | $31.01 | $7.7K | 3,655,906 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2021-04-07 | 2021-04-09 | 1,842 | $32.84 | $60.5K | 3,701,657 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2021-04-07 | 2021-04-09 | 777 | $33.84 | $26.3K | 3,700,880 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2021-04-07 | 2021-04-09 | 3,164 | $32.07 | $101.5K | 3,703,499 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | J Other | 2021-04-07 | 2021-04-09 | 15,670 | — | $0 | 3,685,210 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | S Sale | 2021-02-10 | 2021-02-12 | 183,051 | $20.00 | $3.66M | 3,238,306 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | S Sale | 2021-02-09 | 2021-02-09 | 9,400 | $20.25 | $190.3K | 3,421,357 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | S Sale | 2021-02-08 | 2021-02-09 | 72,128 | $20.04 | $1.45M | 3,430,757 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | S Sale | 2021-02-05 | 2021-02-09 | 10,172 | $20.01 | $203.5K | 3,502,885 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | S Sale | 2021-02-04 | 2021-02-04 | 29,730 | $20.37 | $605.6K | 3,513,057 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | S Sale | 2021-02-03 | 2021-02-04 | 41,922 | $20.21 | $847.2K | 3,542,787 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | S Sale | 2021-02-02 | 2021-02-04 | 48,421 | $20.13 | $974.7K | 3,584,709 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | S Sale | 2021-01-27 | 2021-01-27 | 706,825 | $20.00 | $14.14M | 3,633,130 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | S Sale | 2021-01-26 | 2021-01-27 | 1,363 | $21.08 | $28.7K | 4,339,955 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | S Sale | 2021-01-25 | 2021-01-27 | 13,006 | $21.23 | $276.1K | 4,341,318 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | S Sale | 2021-01-22 | 2021-01-22 | 24,695 | $21.72 | $536.4K | 4,354,324 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | S Sale | 2021-01-21 | 2021-01-22 | 20,979 | $22.11 | $463.8K | 4,384,106 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | S Sale | 2021-01-21 | 2021-01-22 | 200 | $23.77 | $4.8K | 4,379,019 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | S Sale | 2021-01-21 | 2021-01-22 | 4,887 | $22.61 | $110.5K | 4,379,219 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | J Other | 2021-01-20 | 2021-01-22 | 101,646 | — | $0 | 4,405,085 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | S Sale | 2021-01-20 | 2021-01-22 | 2,000 | $24.71 | $49.4K | 4,506,731 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | S Sale | 2021-01-20 | 2021-01-22 | 15,694 | $23.95 | $375.9K | 4,508,731 | SEC↗ |
| ONCR Oncorus, Inc. | C Conversion deriv | 2020-10-06 | 2020-10-08 | 775,975 | — | $0 | 0 | SEC↗ |
| ONCR Oncorus, Inc. | C Conversion deriv | 2020-10-06 | 2020-10-08 | 1,783,879 | — | $0 | 0 | SEC↗ |
| ONCR Oncorus, Inc. | P Buy | 2020-10-06 | 2020-10-08 | 173,776 | $15.00 | $2.61M | 2,849,453 | SEC↗ |
| ONCR Oncorus, Inc. | C Conversion | 2020-10-06 | 2020-10-08 | 1,783,879 | — | $0 | 1,899,702 | SEC↗ |
| ONCR Oncorus, Inc. | C Conversion | 2020-10-06 | 2020-10-08 | 775,975 | — | $0 | 2,675,677 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | C Conversion deriv | 2020-07-28 | 2020-07-29 | 255,094 | — | $0 | 0 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | C Conversion deriv | 2020-07-28 | 2020-07-29 | 3,824,591 | — | $0 | 0 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | C Conversion deriv | 2020-07-28 | 2020-07-29 | 131,645 | — | $0 | 0 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | C Conversion deriv | 2020-07-28 | 2020-07-29 | 2,415,530 | — | $0 | 0 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | C Conversion deriv | 2020-07-28 | 2020-07-29 | 128,384 | — | $0 | 0 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | C Conversion deriv | 2020-07-28 | 2020-07-29 | 47,674 | — | $0 | 0 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | C Conversion deriv | 2020-07-28 | 2020-07-29 | 29,440 | — | $0 | 0 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | C Conversion deriv | 2020-07-28 | 2020-07-29 | 79,281 | — | $0 | 0 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | C Conversion deriv | 2020-07-28 | 2020-07-29 | 1,491,666 | — | $0 | 0 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | C Conversion deriv | 2020-07-28 | 2020-07-29 | 81,295 | — | $0 | 0 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | C Conversion deriv | 2020-07-28 | 2020-07-29 | 157,529 | — | $0 | 0 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | C Conversion deriv | 2020-07-28 | 2020-07-29 | 2,361,805 | — | $0 | 0 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | C Conversion | 2020-07-28 | 2020-07-29 | 724,702 | — | $0 | 1,993,932 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | C Conversion | 2020-07-28 | 2020-07-29 | 1,269,230 | — | $0 | 1,269,230 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | C Conversion | 2020-07-28 | 2020-07-29 | 84,655 | — | $0 | 84,655 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | C Conversion | 2020-07-28 | 2020-07-29 | 43,687 | — | $0 | 43,687 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | C Conversion | 2020-07-28 | 2020-07-29 | 801,619 | — | $0 | 801,619 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | C Conversion | 2020-07-28 | 2020-07-29 | 42,605 | — | $0 | 42,605 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | C Conversion | 2020-07-28 | 2020-07-29 | 15,820 | — | $0 | 15,820 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | C Conversion | 2020-07-28 | 2020-07-29 | 48,336 | — | $0 | 132,991 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | C Conversion | 2020-07-28 | 2020-07-29 | 24,944 | — | $0 | 68,381 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | C Conversion | 2020-07-28 | 2020-07-29 | 457,706 | — | $0 | 1,259,325 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | C Conversion | 2020-07-28 | 2020-07-29 | 24,326 | — | $0 | 66,931 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | C Conversion | 2020-07-28 | 2020-07-29 | 9,033 | — | $0 | 24,853 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | P Buy | 2020-07-28 | 2020-07-29 | 89,955 | $19.00 | $1.71M | 2,083,887 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | P Buy | 2020-07-28 | 2020-07-29 | 5,994 | $19.00 | $113.9K | 138,985 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | P Buy | 2020-07-28 | 2020-07-29 | 3,096 | $19.00 | $58.8K | 71,727 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | P Buy | 2020-07-28 | 2020-07-29 | 56,814 | $19.00 | $1.08M | 1,316,139 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | P Buy | 2020-07-28 | 2020-07-29 | 3,020 | $19.00 | $57.4K | 69,951 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | P Buy | 2020-07-28 | 2020-07-29 | 1,121 | $19.00 | $21.3K | 25,974 | SEC↗ |
| RPTX Repare Therapeutics Inc. | C Conversion deriv | 2020-06-23 | 2020-06-25 | 1,801,581 | — | $0 | 0 | SEC↗ |
| RPTX Repare Therapeutics Inc. | C Conversion deriv | 2020-06-23 | 2020-06-25 | 952,191 | — | $0 | 0 | SEC↗ |
| RPTX Repare Therapeutics Inc. | C Conversion | 2020-06-23 | 2020-06-25 | 1,801,581 | — | $0 | 1,801,581 | SEC↗ |
| RPTX Repare Therapeutics Inc. | P Buy | 2020-06-23 | 2020-06-25 | 250,000 | $20.00 | $5.00M | 3,003,772 | SEC↗ |
| RPTX Repare Therapeutics Inc. | C Conversion | 2020-06-23 | 2020-06-25 | 952,191 | — | $0 | 2,753,772 | SEC↗ |
| TCRR TCR2 THERAPEUTICS INC. | C Conversion deriv | 2019-02-19 | 2019-02-21 | 17,500,000 | — | $0 | 0 | SEC↗ |
| TCRR TCR2 THERAPEUTICS INC. | C Conversion deriv | 2019-02-19 | 2019-02-21 | 2,000,000 | — | $0 | 0 | SEC↗ |
| TCRR TCR2 THERAPEUTICS INC. | C Conversion | 2019-02-19 | 2019-02-21 | 2,825,396 | — | $0 | 3,021,298 | SEC↗ |
| TCRR TCR2 THERAPEUTICS INC. | P Buy | 2019-02-19 | 2019-02-21 | 706,666 | $15.00 | $10.60M | 4,050,865 | SEC↗ |
| TCRR TCR2 THERAPEUTICS INC. | C Conversion | 2019-02-19 | 2019-02-21 | 322,901 | — | $0 | 3,344,199 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | X Exercise deriv | 2019-02-12 | 2019-02-14 | 25,418 | — | $0 | 0 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | C Conversion deriv | 2019-02-12 | 2019-02-14 | 1,525,164 | — | $0 | 0 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | C Conversion deriv | 2019-02-12 | 2019-02-14 | 1,578,751 | — | $0 | 0 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | C Conversion deriv | 2019-02-12 | 2019-02-14 | 417,852 | — | $0 | 0 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | X Exercise deriv | 2019-02-12 | 2019-02-14 | 57,192 | — | $0 | 0 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | X Exercise deriv | 2019-02-12 | 2019-02-14 | 171,579 | — | $0 | 0 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | X Exercise deriv | 2019-02-12 | 2019-02-14 | 50,837 | — | $0 | 0 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | X Exercise deriv | 2019-02-12 | 2019-02-14 | 76,256 | — | $0 | 0 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | X Exercise deriv | 2019-02-12 | 2019-02-14 | 50,837 | — | $0 | 0 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | S Sale | 2019-02-12 | 2019-02-14 | 1,524 | $14.00 | $21.3K | 4,274,425 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | P Buy | 2019-02-12 | 2019-02-14 | 250,000 | $14.00 | $3.50M | 4,524,425 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | C Conversion | 2019-02-12 | 2019-02-14 | 1,525,164 | — | $0 | 1,847,227 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | C Conversion | 2019-02-12 | 2019-02-14 | 1,578,751 | — | $0 | 3,425,978 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | C Conversion | 2019-02-12 | 2019-02-14 | 417,852 | — | $0 | 3,843,830 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | X Exercise | 2019-02-12 | 2019-02-14 | 432,119 | $0.05 | $21.6K | 4,275,949 | SEC↗ |